Fingerprint
Dive into the research topics of 'Phase i dose-escalation study of LCL161, an oral inhibitorof apoptosis proteins inhibitor, in patients with advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Jeffrey R. Infante, E. Claire Dees, Anthony J. Olszanski, Shyeilla V. Dhuria, Suman Sen, Scott Cameron, Roger B. Cohen
Research output: Contribution to journal › Article › peer-review